Itälä L, Sillanaukee P
Biomedical Research Center, Alko Ltd, Helsinki, Finland.
Alcohol Alcohol Suppl. 1994;2:509-13.
Screening for alcohol abuse in its early phase, and the diagnosis of alcohol-related organ damage by laboratory tests in clinical settings, have often been unreliable. Protein-acetaldehyde adducts may be helpful in trying to solve this problem and hemoglobin, with its acetaldehyde adducts, appears to be a suitable model for studying protein-acetaldehyde adducts as condensation products of acetaldehyde, a harmful metabolite of ethanol. The modification by acetaldehyde alters the chromatographic properties of the hemoglobin molecule, producing a modified form that can be separated from other hemoglobin forms by cation exchange chromatographic techniques. The methods for the separation of hemoglobin acetaldehyde adducts have been improved in recent years, allowing us today to detect in vitro changes in hemoglobin caused by "physiological" concentrations of acetaldehyde and raising the possibility of developing a method suitable for clinical detection of hemoglobin acetaldehyde adducts.
在早期阶段筛查酒精滥用,以及在临床环境中通过实验室检测诊断与酒精相关的器官损伤,往往并不可靠。蛋白质 - 乙醛加合物可能有助于解决这一问题,而血红蛋白及其乙醛加合物似乎是研究作为乙醇有害代谢产物乙醛的缩合产物的蛋白质 - 乙醛加合物的合适模型。乙醛的修饰改变了血红蛋白分子的色谱性质,产生了一种可以通过阳离子交换色谱技术与其他血红蛋白形式分离的修饰形式。近年来,分离血红蛋白乙醛加合物的方法得到了改进,使我们如今能够检测由 “生理” 浓度乙醛引起的血红蛋白体外变化,并增加了开发一种适用于临床检测血红蛋白乙醛加合物方法的可能性。